Antlia Bioscience, Inc.

Funding and NIH signals

• SEC Form D raise Raised $6M (Form D filed Jun 5, 2026). SEC Form D 0001829522-26-000003 (Jun 5, 2026)
  Evidence (1 event)

  • Jun 5, 2026 · SEC Form D 0001829522-26-000003
    Name of Issuer: Antlia Bioscience, Inc.; CIK: 1829522; Address: Encinitas, CA; Submission type: D; Filing date: 2026-06-05; Industry Group: Biotechnology; Date of First Sale: 2026-05-22; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 20000000; Total Amount Sold: 6000000; Federal exemptions: 06b

Job counts as of Oct 18, 2026. All funding and NIH signals